Cambrex Corporation


Nov 03, 09

NEW STORY
16:21 ET Cambrex Reports Third Quarter 2009 Results

 
Oct 27, 09

13:36 ET Cambrex to Announce Third Quarter 2009 Financial Results on November 3, 2009

 
Oct 20, 09

12:18 ET Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award

 
Sep 16, 09

18:16 ET Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award

 
Aug 24, 09

14:53 ET Cambrex Receives FDA Warning Letter

 
Aug 04, 09

16:20 ET Cambrex Reports Second Quarter 2009 Results

 
Jul 28, 09

08:50 ET Cambrex To Announce Second Quarter 2009 Financial Results on August 4, 2009

 
Jun 04, 09

15:00 ET Cambrex Regains Compliance With Revised NYSE Listing Standards

 
May 05, 09

16:20 ET Cambrex Reports First Quarter 2009 Results

 
Apr 29, 09

08:59 ET Cambrex to Announce First Quarter 2009 Financial Results on May 5, 2009

 
Apr 14, 09

16:45 ET Cambrex Receives Notice Regarding NYSE Listing

 
Feb 11, 09

17:39 ET Cambrex Reports Fourth Quarter and Full Year 2008 Results

 
Feb 06, 09

14:35 ET Cambrex to Announce Fourth Quarter 2008 Financial Results on February 11, 2009

    
Jan 05, 09

14:00 ET Cambrex Presentation at The JPMorgan Healthcare Conference to be Webcast

    
Nov 04, 08

16:05 ET Cambrex Reports Third Quarter 2008 Results

    
Oct 23, 08

13:25 ET Cambrex to Announce Third Quarter 2008 Financial Results on November 4, 2008

    
Aug 05, 08

16:15 ET Cambrex Reports Second Quarter 2008 Results

    
Jul 22, 08

07:15 ET Cambrex to Announce Second Quarter 2008 Financial Results on August 5, 2008

    
May 15, 08

08:30 ET Cambrex Appoints Steven M. Klosk as President and CEO

    
May 01, 08

16:01 ET Cambrex Reports First Quarter 2008 Results

    
Apr 24, 08

07:38 ET Cambrex to Announce First Quarter 2008 Financial Results on May 1, 2008

    
Mar 21, 08

15:44 ET Cambrex Customer Announced Recall

    
Feb 14, 08

19:23 ET Cambrex Reports Fourth Quarter and Full-Year 2007 Results

    
Feb 12, 08

14:00 ET Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008

    
Jan 07, 08

14:00 ET Cambrex Signs Agreement To Acquire ProSyntest AS

    
Jan 03, 08

13:55 ET Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast

    
Nov 01, 07

16:20 ET Cambrex Reports Third Quarter 2007 Results

    
Oct 25, 07

11:25 ET Cambrex To Announce Third Quarter 2007 Financial Results on November 1, 2007

    
Aug 06, 07

17:35 ET Cambrex Reports Second Quarter 2007 Results

    
Jul 17, 07

07:50 ET Cambrex to Announce Second Quarter 2007 Financial Results on August 6, 2007

    
May 08, 07

18:55 ET Cambrex Reports First Quarter 2007 Results

    
Apr 25, 07

13:15 ET Cambrex to Announce First Quarter 2007 Financial Results on May 8, 2007

    
Apr 06, 07

11:17 ET Cambrex Announces Declaration of Special Cash Dividend, Closing on New Credit Facility, and Discontinuance of Regular Dividend

    
Mar 14, 07

22:48 ET Cambrex Reports Fourth Quarter and Full Year 2006 Results and Provides 2007 Guidance

    
Mar 02, 07

13:05 ET Cambrex to Announce Fourth Quarter and Full Year 2006 Financial Results on March 14, 2007

    
Feb 09, 07

12:35 ET Cambrex Announces New Leadership Team

    
Feb 06, 07

16:10 ET Cambrex Completes Sale of Bio Businesses

    
Feb 05, 07

16:50 ET Cambrex Shareholders Approve Sale of Bio Businesses

    
Jan 30, 07

13:55 ET Cambrex Announces Special Meeting of Shareholders

    
Jan 26, 07

09:10 ET Cambrex Corporation Reports Quarterly Dividend

    
Jan 04, 07

17:45 ET Cambrex Sets Date for Special Meeting of Shareholders to Vote on Sale of Bioproducts and Biopharma Subsidiaries

    
Jan 03, 07

14:30 ET Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast

    
Oct 30, 06

23:19 ET Cambrex Reports Third Quarter 2006 Results

    
15:30 ET Cambrex Completes Sale of Two Non-Strategic Human Health Facilities

    
Oct 27, 06

09:05 ET Cambrex Corporation Reports Quarterly Dividend

    
Oct 24, 06

01:30 ET Cambrex Announces Sale of Bioproducts and Biopharma Subsidiaries to Lonza for $460 Million In Cash

    
Oct 20, 06

07:40 ET Cambrex Announces Sale of Two Non-Strategic Human Health Facilities

 
Oct 13, 06

07:55 ET Cambrex to Announce Third Quarter 2006 Financial Results on October 30, 2006

    
Aug 02, 06

09:00 ET Gary L. Mossman, Executive Vice President & Chief Operating Officer, Announces Retirement

    
Jul 27, 06

19:39 ET Cambrex Reports Second Quarter 2006 Results

    
Jul 17, 06

16:00 ET Cambrex and Ortec Submit to FDA a Humanitarian Device Exemption (HDE) for OrCel(R) to Treat Epidermolysis Bullosa Patients

    
Jul 05, 06

13:30 ET Cambrex to Announce Second Quarter 2006 Financial Results on July 27, 2006

    
Jun 13, 06

09:00 ET Cambrex Corporation and Cytori Therapeutics Enter Into Collaboration to Provide Adipose Derived Stem Cell Research Products

    
May 23, 06

15:05 ET Cambrex Manufacturing Merrimack Pharmaceuticals MM-093

    
Apr 27, 06

17:43 ET Cambrex Reports First Quarter 2006 Results

    
Apr 06, 06

16:10 ET Cambrex to Announce First Quarter 2006 Financial Results on April 27, 2006

    
Mar 31, 06

12:14 ET Cambrex Corporation Announces Delay In Filing Its 2005 Form 10-K Annual Report

    
Feb 23, 06

10:22 ET Cambrex Reports Fourth Quarter and Full Year 2005 Results

    
Feb 21, 06

19:00 ET Cambrex Licenses Cell Line to Chugai Pharmaceutical Co.

    
Feb 02, 06

17:30 ET Cambrex Acquires Cutanogen Corporation

    
15:20 ET Cambrex Presentation at the UBS Global Healthcare Services Conference to be Webcast

    
08:46 ET Cambrex Provides Update On Strategic Path and Certain Other Matters

    
Jan 26, 06

17:00 ET Cambrex Corporation Reports Quarterly Dividend

    
Jan 18, 06

14:50 ET Cambrex Corporation to Announce Fourth Quarter and Year End 2005 Financial Results on February 22, 2006

    
Jan 04, 06

15:10 ET Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast

    
11:00 ET Cambrex Revises Strategic Direction and Announces Senior Management Transition Plan

    
Dec 19, 05

16:19 ET Cambrex Named First Biopharmaceutical Manufacturing Partner for Pfenex Expression Technology(TM) From Dowpharma(SM)

 
Nov 07, 05

15:00 ET David DeMarco, Cambrex Vice President Strategic Planning, Assumes Responsibility for Corporate Development

    
Nov 03, 05

11:27 ET Cambrex to Present at First Analysis Investment Conference

    
Nov 01, 05

16:56 ET Cambrex Comments on Impact of Customer's Recent Clinical Results

    
Oct 27, 05

20:49 ET Cambrex Reports Third Quarter 2005 Results

    
Oct 04, 05

08:00 ET Innovative Biosensors, Inc. and Cambrex Establish Manufacturing Relationship

    
Sep 30, 05

11:58 ET Shawn P. Cavanagh is Appointed Senior Vice President and General Manager, Cambrex Bioproducts

    
Sep 28, 05

13:34 ET Cambrex Corporation to Announce Third Quarter 2005 Financial Results on October 27, 2005

    
Sep 19, 05

08:00 ET Cambrex Hosts Annual Analyst Meeting and Webcast

    
Sep 15, 05

16:41 ET Dr. Chris Dale, Vice President, Technology, Cambrex Biopharmaceuticals and Dr. Robert N. Brey, Chief Scientific Officer, DOR BioPharma will be Speakers at the BioProcess International(TM) World 2005 Conference

    
16:16 ET Cambrex to Present at UBS Global Life Sciences Conference

    
Aug 25, 05

14:45 ET Cambrex to Present at Thomas Weisel Partners' Healthcare Tailwinds 2005 Conference

 
Jul 28, 05

19:39 ET Cambrex Announces Second Quarter 2005 Financial Results

    
Jun 30, 05

13:47 ET Cambrex Corporation Second Quarter 2005 Earnings Release, Conference Call and Webcast

    
Jun 03, 05

09:58 ET David R. Bethune Joins the Cambrex Board of Directors

    
May 09, 05

16:34 ET David DeMarco Appointed Cambrex Vice President Strategic Planning

    
13:23 ET Cambrex to Present at the Banc of America Securities 2005 Healthcare Conference

    
Apr 28, 05

20:42 ET Cambrex Announces First Quarter 2005 Financial Results

    
Apr 25, 05

17:07 ET Dr. Daniel Marshak, Cambrex Chief Technology Officer to Participate in Wall Street Reporter Stem Cell Roundtable

    
Apr 19, 05

09:46 ET Cambrex Presentation at The Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference to be Broadcast on the Internet

    
Apr 11, 05

16:41 ET Cambrex Corporation First Quarter 2005 Earnings Release, Conference Call and Webcast

    
Mar 15, 05

18:37 ET Cambrex Files Extension for Form 10-K and Adjusts 2004 Results

    
Jan 31, 05

16:51 ET Cambrex Presentation at the UBS Global Healthcare Services Conference to be Broadcast Live on the Internet

    
Jan 27, 05

21:43 ET Cambrex Reports 15% Sales Increase In The Fourth Quarter 2004

    
Jan 18, 05

08:31 ET Cambrex Licenses Powerful Technologies for Conditionally Immortalized Cells For Use in Drug Discovery

    
Jan 07, 05

08:30 ET DOR BioPharma and Cambrex Enter into a Development and Manufacturing Process Agreement for RiVax(TM)

    
Jan 04, 05

10:05 ET Cambrex Corporation Announces Fourth Quarter and Year-End 2004 Earnings Release, Conference Call and Webcast

    
Dec 29, 04

15:36 ET Cambrex Presentation at the JPMorgan Healthcare Conference to Be Webcast

 
Nov 09, 04

16:44 ET Cambrex Provides Novartis Proprietary Taste Masking System

 
Nov 03, 04

10:58 ET Cambrex Presentation at The CIBC World Markets Fifteenth Annual Healthcare Conference to be Webcast

    
Oct 28, 04

18:36 ET Cambrex Corporation Reports Quarterly Dividend

 
18:35 ET Cambrex Announces Third Quarter 2004 Results

 
Oct 26, 04

10:14 ET Cambrex Licenses Contaminant Detection Technology from the Johns Hopkins University

    
Oct 20, 04

08:07 ET Cambrex Acquires Innovative Rapid Microbial Detection Company

 
Oct 18, 04

08:04 ET Cambrex and Ortec International Partner to Market ORCEL(R) in the US

 
Oct 14, 04

16:11 ET Cambrex and Epoch Biosciences Announce Licensing Deal For Rapid Microbial Detection

 
Oct 06, 04

12:00 ET Cambrex Hosts Analyst Meeting and Webcast

    
Sep 30, 04

16:29 ET Cambrex Corporation Announces Third Quarter 2004 Earnings Release, Conference Call And Webcast

 
Sep 27, 04

18:03 ET Cambrex Reviews 2004 Outlook On Conference Call

 
Sep 14, 04

15:15 ET Cambrex Presentation at The UBS Global Life Sciences Conference to Be Webcast

    
Aug 24, 04

14:15 ET Cambrex Presentation at the Thomas Weisel Healthcare Tailwinds Conference to be Webcast

    
Aug 02, 04

16:05 ET Cambrex Appoints John R. Leone as President and CEO

    
Jul 22, 04

18:24 ET Cambrex Corporation Reports Quarterly Dividend

    
18:22 ET Cambrex Announces Second Quarter 2004 Results

    
Jul 01, 04

14:58 ET Cambrex Corporation Announces Second Quarter 2004 Earnings Release, Conference Call and Webcast

    
May 11, 04

10:58 ET Cambrex Presentation at the Banc of America Securities Health Care Conference to Be Broadcast Live on the Internet

    
Apr 29, 04

10:03 ET Cambrex Hosts Annual Analyst Meeting and Webcast

    
Apr 22, 04

18:01 ET Cambrex Announces First Quarter 2004 Results

    
12:27 ET Cambrex Corporation Reports Quarterly Dividend

 
Apr 06, 04

14:29 ET Cambrex Corporation Announces First Quarter 2004 Earnings Release, Conference Call and Webcast

    
Mar 05, 04

16:33 ET Cambrex Concludes Valuation Assessment on $5.0 Million Equity Investment and Separately Adjusts Third Quarter 2003 Deferred Tax Valuation Allowance

    
Feb 26, 04

10:43 ET Cambrex Presentation at the Lehman Brothers 7th Annual Global Healtchare Conference to Be Broadcast Live on the Internet

    
Jan 23, 04

16:01 ET Cambrex Provides Retrospective Quarterly Data for the New Business Segments

    
Jan 22, 04

23:52 ET Cambrex Announces Fourth Quarter and Full Year 2003 Results and Provides 2004 Guidance

    
14:18 ET Cambrex Corporation Reports Quarterly Dividend

    
Jan 12, 04

09:47 ET Cambrex Presentation at the UBS Global Healthcare Services Conference to Be Broadcast Live on the Internet

    
Jan 07, 04

09:41 ET Cambrex Presentation at the JPMorgan 22nd Annual Healthcare Conference to be Broadcast Live on the Internet

    
Jan 05, 04

08:46 ET Cambrex Corporation Announces Fourth Quarter And Year-End 2003 Earnings Release, Conference Call and Webcast

    
Dec 01, 03

10:13 ET Cambrex Appoints Edward Robinson Executive Vice President - Europe of the Pharma and Biopharmaceutical Business Unit

    
Nov 19, 03

14:25 ET Gary Mossman Appointed President and CEO of Cambrex Pharma and Biopharmaceutical Business Unit

    
Nov 10, 03

18:23 ET Cambrex Completes Sale of Rutherford Chemicals

    
Nov 06, 03

09:42 ET Cambrex Presentation at the JPMorgan 2nd Annual Small Cap Conference to Be Broadcast Live on the Internet

    
Nov 05, 03

11:44 ET Cambrex Presentation at the CIBC World Markets Fourteenth Annual Healthcare Conference to be Broadcast Live on the Internet

    
Oct 29, 03

08:46 ET Cambrex Announces $100 Million Debt Private Placement

    
Oct 27, 03

01:00 ET Cambrex Announces New Chiral Technologies

    
Oct 24, 03

11:16 ET Cambrex Corporation Reports Quarterly Dividend

    
Oct 23, 03

18:37 ET Cambrex Announces Third Quarter 2003 Results

    
Oct 17, 03

16:53 ET Cambrex Amends Asset Purchase Agreement for Rutherford Chemicals

    
Oct 14, 03

09:57 ET Cambrex Presentation at the First Analysis Life Sciences Track Institutional Investors Conference to Be Broadcast Live on the Internet

    
Oct 13, 03

18:35 ET Ligand and Cambrex Complete New 5-Year Agreement to Manufacture Ligand's Cancer Drug ONTAK(R) and Second-Generation Product

    
Sep 25, 03

11:46 ET Cambrex Corporation Announces Third Quarter 2003 Earnings Release, Conference Call and Webcast

    
Sep 17, 03

09:52 ET Cambrex Presentation at the UBS Warburg Global Life Sciences Conference to Be Broadcast Live on the Internet

    
Sep 09, 03

20:00 ET European Production Facility for CellSpray(R) Regulatory Process Initiated for Europe

    
Aug 27, 03

12:20 ET Cambrex Presentation at the Thomas Weisel Partners Healthcare Tailwinds 2003 Conference to be Broadcast Live on the Internet

    
Aug 07, 03

16:29 ET Cambrex Announces Agreement for Sale of Rutherford Chemicals

    
Aug 06, 03

14:50 ET Cambrex Announces Supply Agreement With Genzyme, Haverhill, UK

    
Jul 24, 03

18:03 ET Cambrex Announces Second Quarter 2003 Results of Operations

    
14:32 ET Cambrex Corporation Reports Quarterly Dividend

    
Jul 01, 03

16:11 ET Cambrex Corporation Announces Second Quarter 2003 Earnings Release, Conference Call and Webcast

    
Jun 23, 03

10:26 ET Cambrex Opens New Biopharmaceutical Development Lab and Pilot Plant; A Complete Optimization Resource for Early-Stage Development

 
Jun 09, 03

16:30 ET Cambrex Provides Update on Growth Strategies and Recent Successes at 2003 Investor Day

 
Jun 03, 03

16:36 ET Cambrex to Expand cGMP Cell Therapy Capacity

    
Apr 30, 03

17:02 ET Cambrex Receives Approval Report From Belgian Ministry Of Health For Cell Therapy

    
Apr 25, 03

08:43 ET Cambrex Corporation Reports Quarterly Dividend

    
Apr 24, 03

18:14 ET Cambrex Announces First Quarter 2003 Results of Operations

    
Apr 07, 03

09:36 ET Cambrex Corporation Announces First Quarter 2003 Earnings Release, Conference Call and Webcast

    
Apr 03, 03

16:57 ET Cambrex Revises 2003 Outlook; Announces Decision to Settle Legal Matter

    
Mar 17, 03

10:56 ET Cambrex Presentation at The Banc of America Securities Healthcare Conference On March 25, 2003 to Be Broadcast Live on the Internet

    
Mar 06, 03

16:49 ET Gary Mossman Appointed President Cambrex Pharma Business Unit

    
Feb 26, 03

15:04 ET Cambrex Provides New Pharmaceutical Development Capacity

    
Feb 25, 03

14:56 ET Cambrex Presentation at the McDonald Investments Specialty Chemical Conference On March 5, 2003 to be Broadcast Live on the Internet

    
Feb 24, 03

16:21 ET Cambrex Presentation at the Lehman Brothers Global Healthcare Conference on March 4, 2003 to be Broadcast Live on the Internet

    
Jan 27, 03

17:20 ET Cambrex Presentation at UBS Warburg Healthcare Services Conference on February 5, 2003 to be Broadcast Live on the Internet

    
Jan 24, 03

12:58 ET Cambrex Corrects Certain Year 2000 Data Contained In January 23, 2003 Press Release

    
Jan 23, 03

19:20 ET Cambrex Corporation Reports Quarterly Dividend

    
19:17 ET Cambrex Reports Fourth Quarter 2002 Sales and Income And Identifies Accounting Issue Impacting 1997-2001 Results

    
Jan 21, 03

16:43 ET Claes Glassell, Cambrex President and COO Resigns; James A. Mack, Chairman and CEO to Fulfill Role of President

    
Jan 02, 03

14:03 ET Cambrex Corporation Announces Fourth Quarter And Year-End 2002 Earnings Release, Conference Call And Webcast

    
Dec 20, 02

16:11 ET Cambrex Presentation at JPMorgan 21st Annual Healthcare Conference On January 6, 2003 to be Broadcast Live on the Internet

    
Dec 17, 02

16:01 ET Cambrex Corporation Pursues Strategic Alternatives for Rutherford Chemicals

    
Dec 16, 02

11:33 ET Cambrex Presentation at the NYSSA 7th Annual Specialty Chemical Conference On January 15, 2003 to be Broadcast Live on the Internet

    
Nov 25, 02

13:11 ET Cambrex Presentation at Salomon Smith Barney 13th Annual Chemical Conference on December 4, 2002 to be Broadcast Live on the Internet

    
Nov 20, 02

17:21 ET Cambrex Corporation Announces Organization Changes

    
Nov 04, 02

16:13 ET Peter van Hoorn Appointed President, Cambrex Biopharmaceutical Business Unit

    
Oct 24, 02

13:45 ET Cambrex Corporation Reports Quarterly Dividend

    
Oct 22, 02

20:28 ET Cambrex Corporation Reports Third Quarter 2002 Sales And Income

    
Oct 18, 02

11:58 ET Cambrex Presentation at CIBC World Markets Thirteenth Annual Health Care Conference on November 5, 2002 To Be Broadcast Live on the Internet

    
Oct 17, 02

11:13 ET Cambrex Presentation at First Analysis Investment Conference on November 8, 2002 to Be Broadcast Live on the Internet

    
Oct 01, 02

17:24 ET Cambrex Corporation Reviews Second Half 2002 Outlook

    
Sep 26, 02

10:28 ET Cambrex Presentation at UBS Warburg Global Life Sciences Conference On Cctober 7, 2002 to be Broadcast Live on the Internet

    
Sep 19, 02

16:48 ET Cambrex Corporation Announces Third Quarter 2002 Earnings Release, Conference Call and Webcast

    
Sep 05, 02

11:53 ET Cambrex Presentation at Bear Stearns 15th Annual Health Care Conference On September 17, 2002 to Be Broadcast Live on the Internet

    
Aug 12, 02

15:05 ET Cambrex Announces $26 Million GMP Contract Bioprocessing Capacity Expansions

    
Aug 02, 02

11:14 ET Cambrex Announces $5 Million Laboratory & Pilot Plant Expansion

    
Jul 25, 02

12:39 ET Cambrex Corporation Reports Quarterly Dividend

    
Jul 23, 02

19:58 ET Cambrex Corporation Reports Second Quarter 2002 Sales and Income

    
Jun 17, 02

15:38 ET Cambrex Corporation Announces Second Quarter 2002 Earnings Release, Conference Call and Webcast

    
May 06, 02

11:05 ET Cambrex Presentation at Deutsche Bank Securities 27th Annual Healthcare Conference On May 8th to Be Broadcast Live On the Internet

    
Apr 26, 02

14:59 ET Cambrex Corporation Reports Quarterly Dividend

    
Apr 24, 02

16:29 ET Cambrex at Thomas Weisel Healthcare Tailwinds 2002 Conference on April 29, 2002 to be Broadcast Live on the Internet

    
Apr 23, 02

17:25 ET Cambrex Corporation Reports First Quarter 2002 Sales and Income

    
Apr 18, 02

17:17 ET Cambrex Announces New Reporting Segments

    
Apr 08, 02

14:34 ET Dr. Aaron Heifetz Appointed Vice President, General Manager & Site Director Cambrex Bio Science, Maryland

    
Mar 28, 02

12:14 ET Cambrex Presentation at Banc of America Healthcare Conference On April 4, 2002 to Be Broadcast Live on the Internet

    
Mar 25, 02

13:57 ET Cambrex Co-Sponsors 2002 Apoptosis Conference - Apoptosis: Commercial Opportunities

    
Mar 22, 02

16:33 ET Cambrex Corporation Announces First Quarter 2002 Earnings Release, Conference Call and Webcast

    
Mar 11, 02

16:52 ET Cambrex and BioHeart Complete Cell Therapy Supply Agreement

    
Feb 28, 02

15:33 ET Cambrex Sells In Vitro Diagnostic Product Line

    
Feb 06, 02

14:17 ET Cambrex Appoints Peter G. Tombros to Board of Directors

    
Feb 04, 02

14:55 ET Cambrex Announces Generic Pharmaceutical R&D Laboratory Expansion

    
Jan 31, 02

12:39 ET Cambrex Appoints Chief Technology Officers of Biotechnology and Pharmaceutical Technologies

    
Jan 24, 02

16:44 ET Cambrex Corporation Reports Quarterly Dividend

    
Jan 22, 02

21:09 ET Cambrex Corporation Reports Fourth Quarter and Full Year 2001 Results

    
Dec 12, 01

12:42 ET Cambrex Corporation Announces Fourth Quarter and Year-End 2001 Earnings Release, Conference Call and Webcast

 
Dec 07, 01

11:06 ET Cambrex Withdraws Convertible Subordinated Notes Offering

    
Dec 04, 01

09:15 ET Cambrex Announces Offering of Convertible Subordinated Notes in a 144A/Regulation S Offering

    
Nov 30, 01

13:43 ET Cambrex Announces New Organization to Improve Strategic Focus On Life Sciences

    
Nov 29, 01

15:37 ET Cambrex Announces $430 Million Revolving Credit Line

    
Oct 30, 01

18:17 ET Cambrex Acquires Biopharmaceutical Producer

    
Oct 25, 01

17:11 ET Cambrex Corporation Reports Quarterly Dividend

    
Oct 23, 01

18:11 ET Cambrex Corporation Reports Third Quarter 2001 Earnings

    
Oct 04, 01

19:13 ET Cambrex Corporation Announces Share Repurchase Program

    
Sep 27, 01

12:36 ET Cambrex Corporation Announces Third Quarter 2001 Earnings Release, Conference Call and Webcast

    
Sep 26, 01

09:22 ET Cambrex Reviews Third and Fourth Quarters 2001

    
Jul 26, 01

18:30 ET Cambrex Corporation Reports Quarterly Dividend

    
15:16 ET Claes Glassell Appointed Cambrex Corporation President & Chief Operating Officer

    
Jul 25, 01

13:18 ET Revised Conference Call Replay Toll-Free Number for Second Quarter 2001 Earnings Conference Call

    
Jul 24, 01

17:40 ET Cambrex Corporation Reports Record Second Quarter 2001 Sales and Income

    
Jun 20, 01

11:25 ET Cambrex Corporation Announces Second Quarter 2001 Earnings Release, Conference Call and Webcast

    
Jun 04, 01

11:01 ET Cambrex Corporation Completes Acquisition of the Biopharmaceutical Production Business of Bio Science Contract Production, Corp.

    
Apr 30, 01

16:15 ET Cambrex to Acquire Leading Biopharmaceutical Producer

    
Apr 26, 01

11:39 ET Cambrex Corporation Reports Quarterly Dividend

    
Apr 24, 01

16:50 ET Cambrex Corporation Reports Record First Quarter 2001 Sales and Income

 
Mar 23, 01

16:40 ET Cambrex Corporation Announces First Quarter 2001 Earnings Release, Conference Call and Webcast

    
Mar 15, 01

14:06 ET Cambrex Announces CFO Transition

 
Mar 14, 01

16:46 ET Cambrex Announces CFO Transition

    
Jan 25, 01

12:32 ET Cambrex Corporation Reports Quarterly Dividend

    
Jan 23, 01

18:01 ET Cambrex Corporation Reports Fourth Quarter and Record Full Year 2000 Results

    
Dec 22, 00

10:15 ET Cambrex Corporation Announces Fourth Quarter and Year-End 2000 Earnings Release, Conference Call and Webcast

 
Nov 27, 00

14:16 ET Cambrex Corporation and Synthon Chiragenics Announce Collaborative Agreement for Breakthrough Chiral Compounds

    
Nov 14, 00

13:08 ET Cambrex Corporation Announces the Creation of The Cambrex International Scientific Advisory Board

    
Oct 26, 00

11:53 ET Cambrex Corporation Reports Quarterly Dividend

    
Oct 24, 00

18:37 ET Cambrex Corporation Reports Record Third Quarter 2000 Earnings

    
12:10 ET Cambrex Corporation Announces Webcast of Third Quarter 2000 Conference Call

 
Sep 27, 00

14:46 ET Cambrex Corporation Announces Third Quarter 2000 Earnings Release and Conference Call

    
Sep 21, 00

09:38 ET Cambrex Corporation Announces Supply Agreement With Biocompatibles Ltd.

    
Sep 19, 00

09:57 ET Cambrex Conference Call Replay

    
Sep 18, 00

16:11 ET Cambrex Reviews Third and Fourth Quarters

    
Aug 29, 00

17:03 ET Cambrex Corporation Announces Agreement With Arizona Chemical

    
Jul 31, 00

11:43 ET Claes Glassell Appointed Cambrex Chief Operating Officer

    
Jul 27, 00

11:34 ET Cambrex Corporation Reports Quarterly Dividend

    
Jul 25, 00

16:24 ET Cambrex Corporation Reports Record Second Quarter 2000 Sales and Income

    
Jul 24, 00

10:40 ET Cambrex Corporation Announces Purchase of LumiTech

    
Jun 28, 00

14:50 ET Cambrex Corporation Announces Acquisition Of Picolinates Nutraceutical Product Line

    
Jun 22, 00

13:09 ET Cambrex Corporation Announces Second Quarter 2000 Earnings Release and Conference Call

    
12:35 ET Cambrex Corporation Announces Second Quarter 2000 Earnings Release and Conference Call

    
Jun 13, 00

17:22 ET Cambrex Corporation Announces Agreement With Safe Foods Corporation on New Food Safety Technology

 
Jun 02, 00

09:38 ET Cambrex Corporation Announces Share Repurchase Program

 
May 05, 00

17:48 ET Cambrex Corporation Reaches Settlement with The Department of Justice

 
Apr 27, 00

11:41 ET Cambrex Corporation Reports Quarterly Dividend

 
Apr 25, 00

17:09 ET Cambrex Corporation Reports Record First Quarter 2000 Sales and Income

 
Mar 28, 00

08:14 ET Cambrex Corporation Announces First Quarter 2000 Earnings Release and Conference Call

 
Mar 20, 00

15:16 ET Cambrex Announces Patent for Taxol(R) Side Chain Synthesis

 
Mar 14, 00

10:17 ET Cambrex Corporation Announces New Director, Commercial Development -- Biosciences

 
Mar 13, 00

11:21 ET Cambrex Corporation Plant is Fully Operational

 
Mar 08, 00

18:19 ET Cambrex Corporation Responds to Recent News Concerning Nepera, Inc.

 
Mar 02, 00

15:05 ET Cambrex Corporation Announces The Formation Of The New Innovator Pharmaceutical Business Unit

 
13:09 ET Cambrex Corporation Announces Purchase of Conti BPC NV

 
Feb 08, 00

14:44 ET Cambrex Corporation Announces Strategic E-Commerce Alliance with SciQuest.com, Inc.

 
Jan 27, 00

12:16 ET Cambrex Corporation Reports Quarterly Dividend

 
Jan 25, 00

17:08 ET Cambrex Corporation Reports Fourth Quarter Results And Full Year 1999

 
Jan 12, 00

10:02 ET Cambrex Corporation 1999 Earnings Conference Call

 
Jan 11, 00

10:00 ET Cambrex Corporation Announces Fourth Quarter Expectations

 
Nov 11, 99

14:35 ET Cambrex Center of Technical Excellence

 
Oct 28, 99

12:37 ET Cambrex Corporation Elects James A. Mack Chairman

 
12:17 ET Cambrex Corporation Reports Quarterly Dividend

 
Oct 19, 99

16:04 ET Cambrex Corporation Reports Record Third Quarter Sales and Income

 
Aug 11, 99

13:54 ET Osiris Therapeutics and Cambrex Subsidiary BioWhittaker Form Collaboration for Adult Stem Cells

 
Aug 03, 99

15:42 ET Cambrex Corporation Announces New Product

 
Jul 23, 99

11:00 ET Cambrex Corporation Reports Quarterly Dividend

 
Jul 20, 99

16:53 ET Cambrex Corporation Reports Record Quarterly Sales And Income

 
Jul 19, 99

13:58 ET Cambrex Completes Irotec Production Facility

 
Jul 12, 99

10:52 ET Cambrex Corporation Completes Acquisition of FMC's BioProducts Business

 
Jul 09, 99

12:32 ET Cambrex 1999 Second Quarter Earnings Conference Call

 
Jun 07, 99

09:05 ET Cambrex Corporation Acquires FMC's BioProducts Business

 
May 04, 99

13:06 ET Cambrex Announces $9 Million of Salsbury Expansion Projects

 
Apr 22, 99

12:06 ET Cambrex Corporation Reports Quarterly Dividend

 
Apr 20, 99

14:58 ET Cambrex Corporation Reports Record First Quarter Sales and Income

 
Apr 09, 99

09:00 ET Cambrex 1999 First Quarter Earnings Conference Call

 
Mar 19, 99

09:40 ET Cambrex Announces Management Agreement

 
Mar 16, 99

12:47 ET Cambrex Corporation Announces New Product Segments

 
Mar 12, 99

08:39 ET Cambrex Corporation Announces Pharmaceutical Supply Acquisition

 
Jan 28, 99

12:45 ET Cambrex Corporation Reports Quarterly Dividend

 
Jan 26, 99

16:44 ET Cambrex Corporation Reports Record Fourth Quarter Sales and Income

 
Jan 12, 99

16:24 ET Cambrex Corporation 1998 Earnings Conference Call

 
Dec 28, 98

14:07 ET Cambrex Corporation Announces Biotech Supply Acquisition

 
Dec 22, 98

12:29 ET Cambrex Corporation Responds to FTC Charges

 
Oct 22, 98

11:33 ET Cambrex Corporation Reports Quarterly Dividend

 
Oct 20, 98

16:12 ET Cambrex Corporation Reports Record Third Quarter Sales and Income

 
Oct 13, 98

11:58 ET Cambrex Corporation 1998 Third Quarter Earnings Conference Call

 
Jul 23, 98

10:59 ET Cambrex Corporation Reports Quarterly Dividend

 
Jul 21, 98

09:01 ET Cambrex Corporation Reports Record Second Quarter Sales and Income

 
Jul 10, 98

09:49 ET Cambrex Corporation 1998 Second Quarter Earnings Conference Call

 
May 28, 98

13:53 ET Cambrex Corporation Announces Stock Split

 
May 21, 98

14:03 ET Cambrex Corporation Completes Acquisition of European Biopharmaceutical Manufacturing and Distribution Assets

 
Apr 24, 98

12:45 ET Cambrex Announces New Vitamin B3 Plant

 
Apr 23, 98

11:53 ET Cambrex Corporation Reports Quarterly Dividend

 
Apr 21, 98

15:46 ET Cambrex Corporation Reports Record First Quarter Sales and Income

 
Apr 15, 98

13:47 ET Cambrex Corporation 1998 First Quarter Earnings Conference Call

 
13:34 ET Cambrex Acquires European Biopharmaceutical Manufacturing and Distribution Assets for its Bio Whittaker Subsidiary

 
Feb 23, 98

12:58 ET Cambrex Corporation to List on New York Stock Exchange

 
Jan 22, 98

12:38 ET Cambrex Corporation Reports Quarterly Dividend

 
Jan 20, 98

16:00 ET Cambrex Corporation Reports Fourth Quarter Results And Full Year 1997

 
Jan 09, 98

16:26 ET Cambrex Corporation Completes Chiral Intermediates Purchase

 
Nov 18, 97

13:41 ET Cambrex Corporation Announces R&D Charge

 
08:03 ET Celgene Corporation to Sell Chiral Intermediates Business To Cambrex Corporation

 
Nov 06, 97

11:54 ET Cambrex Corporation Announces Organization Realignment

 
Oct 23, 97

12:10 ET Cambrex Corporation Reports Quarterly Dividend

 
Oct 21, 97

11:10 ET Cambrex Corporation Reports Increased Net Income For Its Third Quarter 1997

 
Oct 03, 97

15:51 ET Cambrex/BioWhittaker Merger Complete

 
Sep 29, 97

17:05 ET Cambrex Announces New $400 Million Credit Line

 
17:05 ET Cambrex Corporation Hires New Vice President of Technology

 
Sep 26, 97

17:06 ET Cambrex Cash Tender Offer for BioWhittaker Succeeds; 93% Of Shares Support Cambrex Offer

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2009 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.